Register for updates

 
 

Medicine & Health
RSS Feed
A Heartbeat Away? Hybrid "Patch" Could Replace Transplants
Tuesday, September 30, 2014 9:30:00 AM

TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch

Because heart cells cannot multiply and cardiac muscles contain few stem cells, heart tissue is unable to repair itself after a heart attack. Now Tel Aviv University researchers are literally setting a new gold standard in cardiac tissue engineering.

Dr. Tal Dvir and his graduate student Michal Shevach of TAU's Department of Biotechnology, Department of Materials Science and Engineering, and Center for Nanoscience and Nanotechnology, have been developing sophisticated micro- and nanotechnological tools — ranging in size from one millionth to one billionth of a meter — to develop functional substitutes for damaged heart tissues. Searching for innovative methods to restore heart function, especially cardiac "patches" that could be transplanted into the body to replace damaged heart tissue, Dr. Dvir literally struck gold. He and his team discovered that gold particles are able to increase the conductivity of biomaterials.

In a study published by Nano Letters, Dr. Dvir's team presented their model for a superior hybrid cardiac patch, which incorporates biomaterial harvested from patients and gold nanoparticles. "Our goal was twofold," said Dr. Dvir. "To engineer tissue that would not trigger an immune response in the patient, and to fabricate a functional patch not beset by signalling or conductivity problems."

A scaffold for heart cells

Cardiac tissue is engineered by allowing cells, taken from the patient or other sources, to grow on a three-dimensional scaffold, similar to the collagen grid that naturally supports the cells in the heart. Over time, the cells come together to form a tissue that generates its own electrical impulses and expands and contracts spontaneously. The tissue can then be surgically implanted as a patch to replace damaged tissue and improve heart function in patients.

According to Dr. Dvir, recent efforts in the scientific world focus on the use of scaffolds from pig hearts to supply the collagen grid, called the extracellular matrix, with the goal of implanting them in human patients. However, due to residual remnants of antigens such as sugar or other molecules, the human patients' immune cells are likely to attack the animal matrix.

In order to address this immunogenic response, Dr. Dvir's group suggested a new approach. Fatty tissue from a patient's own stomach could be easily and quickly harvested, its cells efficiently removed, and the remaining matrix preserved. This scaffold does not provoke an immune response.

Using gold to create a cardiac network

The second dilemma, to establish functional network signals, was complicated by the use of the human extracellular matrix. "Engineered patches do not establish connections immediately," said Dr. Dvir. "Biomaterial harvested for a matrix tends to be insulating and thus disruptive to network signals."

At his Laboratory for Tissue Engineering and Regenerative Medicine, Dr. Dvir explored the integration of gold nanoparticles into cardiac tissue to optimize electrical signaling between cells. "To address our electrical signalling problem, we deposited gold nanoparticles on the surface of our patient-harvested matrix, 'decorating' the biomaterial with conductors," said Dr. Dvir. "The result was that the nonimmunogenic hybrid patch contracted nicely due to the nanoparticles, transferring electrical signals much faster and more efficiently than non-modified scaffolds."

Preliminary test results of the hybrid patch in animals have been positive. "We now have to prove that these autologous hybrid cardiac patches improve heart function after heart attacks with minimal immune response," said Dr. Dvir. "Then we plan to move it to large animals and after that, to clinical trials."

Dr. Dvir has been awarded a fellowship from the American Heart Association, the Marie Curie Award for Young Investigators, the Alon Fellowship for Young Investigators from the Israeli Ministry of Education, and the Slezak Super Center Award for Cardiac Research.




Latest News

Lightning's Electromagnetic Fields May Have Protective Properties

Extremely low frequency fields may have played an evolutionary role in living organisms, say TAU researchers.

Study Links Adult Fibromyalgia to Childhood Sexual Abuse

Hyperbaric oxygen therapy sessions are an effective treatment, TAU researchers say.

Adolescents With Celiac Disease Are at Higher Risk of Eating Disorders

Overweight teenage girls with CD are at highest risk of developing early hallmarks of full-blown eating disorders, TAU researchers say.

White Blood Cells Related to Allergies and Asthma May Also Be Harnessed to Destroy Cancer Cells

Eosinophil immune cells are capable of killing colon cancer cells, TAU researchers say.

New Yeast Model of Metabolic Disorders May Lead to Life-saving Therapies

Unicellular organism mimics pathology and symptoms of congenital diseases, TAU researchers say.

TAU-Led International Team Discovers New Way Supermassive Black Holes Are "Fed"

These "giant monsters" were observed suddenly devouring gas in their surroundings.

New Biomarker Links Cancer Progression to Genome Instability

High level of specific protein in tumors indicates prognosis as well as optimal treatments, TAU researchers say.

Microplastics and Plastic Additives Discovered in Ascidians All Along Israel's Coastline

TAU report is first to assess presence of plastic additives in Eastern Mediterranean and Red Sea marine life.

Heart Cell Defect Identified as Possible Cause of Heart Failure in Pregnancy

TAU research has diagnostic and therapeutic implications.

Sustainable "Plastics" Are on the Horizon

New sustainable biopolymer technology developed by TAU researchers may one day free the world of its worst pollutant.

contentSecondary
c

© 2019 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University